Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.230
-0.120 (-5.11%)
Sep 22, 2026, 4:00 PM EDT - Market closed
Cellectar Biosciences Employees
Cellectar Biosciences had 11 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,029,427
Market Cap
21.08M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11 | 0 | - |
| Dec 31, 2024 | 11 | -9 | -45.00% |
| Dec 31, 2023 | 20 | 5 | 33.33% |
| Dec 31, 2022 | 15 | 3 | 25.00% |
| Dec 31, 2021 | 12 | 1 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 138 |
| Jasper Therapeutics | 22 |
| Atossa Therapeutics | 16 |
| Tvardi Therapeutics | 12 |
| Actuate Therapeutics | 12 |
| Psyence Biomedical | 12 |
| Cocrystal Pharma | 10 |
| Polyrizon | 4 |
CLRB News
- 5 weeks ago - Cellectar Biosciences Transcript: Study update - Transcripts
- 5 weeks ago - Cellectar Biosciences Slides: Study update - Filings
- 5 weeks ago - Cellectar Biosciences Slides: Corporate presentation - Filings
- 5 weeks ago - Cellectar Biosciences reports Q2 EPS (57c), consensus (52c) - TheFly
- 5 weeks ago - Cellectar Biosciences Earnings Call Transcript: Q2 2026 - Transcripts
- 5 weeks ago - Cellectar Biosciences Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Cellectar Biosciences Earnings release: Q2 2026 - Filings
- 5 weeks ago - Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire